Potentiations of N-methylcarbamate toxicities by organophosphorus insecticides in male mice

Abstract A N -methylcarbamate insecticide, 2- sec -butylphenyl N -methylcarbamate (BPMC), is markedly potentiated by low-dose treatments of PS type organophosphorus insecticides. As a mechanism of this potentiation, the increase of plasma BPMC concentrations due to the inhibited metabolic degradation has been suggested. In this study, acute toxicities of five N -methylcarbamates structurally related to BPMC were studied after low-dose treatments of three PS type organophosphorus insecticides (cyanophos, fenitrothion, and malathion) and one PS type organophosphorus insecticide (dichlorvos), and the role of plasma concentrations of N -methylcarbamates in the potentiations was examined. Acute toxicities of five N -methylcarbamates were potentiated by the treatments of the PS types, among which the potentiation of BPMC was strongest. BPMC toxicity was not potentiated by the treatment of the PO type. Plasma concentrations of BPMC were increased by the treatments of the PS types, but not by the treatment of the PO type. The acute toxicity and plasma concentrations of BPMC were increased by SKF 525-A (an inhibitor of mixed-function oxidase). These results suggest that the increase of plasma BPMC concentrations may be related to the potentiation of BPMC toxicity. The treatment of fenitrothion increased plasma concentrations of other N -methylcarbamates more than those of BPMC, although the potentiation of BPMC toxicity was strongest. SKF 525-A and fenitrothion treatments increased plasma BPMC concentrations to a similar degree, but the potentiation of BPMC toxicity by SKF 525-A was significantly less than that by fenitrothion. Thus, some other mechanism(s) may be responsible for the potentiations of the N -methylcarbamate toxicities.